Skip to main content
LXRX logo

LXRX · Lexicon Pharmaceuticals, Inc. · Documents

Track LXRX — free
$1.79 -0.03 (-1.65%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$796.97M
Shares
445.23M
Volume · Nov 13 1.89M Avg daily vol (3M) 2.62M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2020
Oct 30
Quarterly report 10-Q FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $6.63M ▼ 97.7% Net income $82.6M ▼ 63.5% Diluted EPS $0.71 ▼ 63.6%
Mar 12
Annual report 10-K FY2019, ended Dec 31
Annual report for FY2019
Revenue $322.07M ▲ 409.5% Net income $130.13M Diluted EPS $1.16
Showing 151–176 of 176 documents
Key facts CIK 1062822 CUSIP 528872302 13F (30d) 122 filings 108 filers Visit website Investor relations